Transgender Women's Experiences Using a Home HIV-Testing Kit for Partner-Testing
- PMID: 32193729
- PMCID: PMC7725406
- DOI: 10.1007/s10461-020-02829-x
Transgender Women's Experiences Using a Home HIV-Testing Kit for Partner-Testing
Abstract
HIV partner-testing (PT) may represent a unique and empowering HIV prevention strategy for groups that face structural and institutional barriers to HIV testing and care, including transgender women. We report on in-depth interviews (IDIs) with N = 10 transgender women who used HIV self-test kits for three months to screen potential sexual partners in a randomized controlled trial (iSUM; "I'll Show You Mine") that took place in New York City and San Juan, Puerto Rico. Participants were assigned to intervention (supplied with 10 self-test kits immediately) or control groups (received 6 test kits after 3 months). We conducted IDIs with the first N = 10 transgender women to enroll in the intervention group after three months in the study (after participants used kits with partners) to understand their experiences. Themes discussed in IDIs included: partners' reaction to HIV testing, participants' reactions to partners' test results or refusal to test, partners' own reaction to their test results, and decision-making around test use. Data were independently analyzed by two coders. Overwhelmingly, participants' experiences with PT was positive. Participants reported kits were convenient and acceptable to most partners. Transgender women felt that PT could pose additional risk for them; one woman experienced violence related to kit use. Furthermore, the availability of kits appeared to encourage participants and their partners to think about their HIV status and, in some cases, modify sexual behavior. Work suggests that HIV PT could be a viable risk-reduction strategy for transgender women.
Keywords: HIV; HIV self-test; HIV testing; HIV/AIDS; Male partners; OraQuick; Partner HIV testing; Secondary distribution; Trans women; Transgender women; Transwomen.
References
-
- Baral SD, Poteat T, Stromdahl S, Wirtz AL, Guadamuz TE, Beyrer C. Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. Lancet Infect Dis 2013;13:214–222. - PubMed
-
- WHO. Consolidated guidelines on HIV prevention, diagnosism treatment and care for key populations. Geneva, Switzerland: World Health Organization; 2014. - PubMed
MeSH terms
Substances
Grants and funding
- KL2 TR001870/TR/NCATS NIH HHS/United States
- T15 LM007079/LM/NLM NIH HHS/United States
- K12 HS026383/HS/AHRQ HHS/United States
- P30 MH043520/MH/NIMH NIH HHS/United States
- UM1 AI069415/AI/NIAID NIH HHS/United States
- R01 HD076636/HD/NICHD NIH HHS/United States
- P60 MD006902/MD/NIMHD NIH HHS/United States
- U19 AI113127/AI/NIAID NIH HHS/United States
- R01 LM013045/LM/NLM NIH HHS/United States
- P30 MH43520/MH/NIMH NIH HHS/United States
- R01 LM012355/LM/NLM NIH HHS/United States
- K01 MH115785/MH/NIMH NIH HHS/United States
- R01 AI113127/National Institute of Child Health and Human Development
LinkOut - more resources
Full Text Sources
Medical